Thomas, McNerney & Partners
Venture capital · Stamford, Connecticut, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
2Deep-tech portfolio0 active
2Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Gossamer Bio
18Co-investorsShare a portfolio company
Portfolio · 2 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Gossamer Bio | Biotech | Public | Sep 4, 2026 | $728.1M |
| Translate Bio | Biotech | Acquired | May 10, 2019 | $98.5M |
Peer ranks
Portfolio size#189
Portfolio exits#103
Raises, 12 months#22
Co-investors#116
Co-investors
- Telegraph Hill PartnersVenture capital2 shared
- Atlas VentureVenture capital1 shared
- Charter Life SciencesVenture capital1 shared
- Gurnet Point CapitalVenture capital1 shared
- H.I.G. BioHealth PartnersVenture capital1 shared
- Lightstone VenturesVenture capital1 shared
- Longitude CapitalVenture capital1 shared
- ModernaVenture capital1 shared
- MPM BioImpactVenture capital1 shared
- MPM CapitalVenture capital1 shared
Sectors
- Biotech2
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.